Status:

COMPLETED

Study of Insulin Therapy Augmented by Real Time Sensor IN Type 1 Children and Adolescents (START-IN!)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

2-18 years

Phase:

PHASE2

PHASE3

Brief Summary

Glycemic control in children and adolescent with type 1 diabetes remains inadequate, exposing them to the risk of vascular complications in adulthood. One of the limiting factors is the daily number ...

Detailed Description

Despite the development of intensive insulin therapy, glycemic control defined by glycated haemoglobin (HbA1c) \< 7,5% remains inadequate in pediatric patients with type 1 diabetes. Improvement of th...

Eligibility Criteria

Inclusion

  • Age between 2 years and 17 years 11 months.
  • Onset of type 1 diabetes ≥ 1 year.
  • Centralized HPLC HbA1c ≥ 7.5% and \< 11%.
  • Intensive insulin therapy either by multiple daily injections ≥ 3 / day (rapid insulin analogue before 3 meal and 1 to 2 injections of basal insulin) or by continuous subcutaneous insulin infusion (pump).
  • Followed in the centre for ≥ 3 months.
  • Blood glucose self-monitoring ≥ 2/day.
  • No significant change of regimen insulin therapy for at least 3 months.
  • Patient receiving medical health insurance.
  • Patient who has given his consent

Exclusion

  • Non type 1 diabetes(type 2 diabetes or diabetes whose evolution suggest other origin).
  • Association with another pathology which, in the discretion of the investigator, could affect the monitoring or be disturbed by the participation in the study.
  • Association with chronic treatment (steroids, growth hormone…) or chronic disease, including hypothyroidism and celiac disease, non stabilized for 3 months.
  • Association with severe skin disease.
  • Deafness, hearing or visual defect.

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2012

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00949221

Start Date

September 1 2009

End Date

July 1 2012

Last Update

February 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Robert Debré

Paris, France, 75019

Study of Insulin Therapy Augmented by Real Time Sensor IN Type 1 Children and Adolescents (START-IN!) | DecenTrialz